Article
The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients.
Leukemia research - 1 Feb 2022
Sumiyoshi Ritsu, Tashiro Haruko, Shirasaki Ryosuke, Matsuo Takuji, Yamamoto Tadashi, Matsumoto Kensuke, Ooi Jun, Shirafuji Naoki
Abstract excerpt
The role of the FMS-like tyrosine kinase 3 (FLT3) gene in acute myeloid leukemia (AML) has been well documented and the FLT3-internal tandem duplication (FLT3-ITD) mutation has been identified as a prognostic factor in AML. Due to its low incidence, the role of the FLT3 mutation remains unclear in myelodysplastic syndrome (MDS) patients. To investigate the impact of the FLT3-ITD status on the prognosis of MDS at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
